Sign in

CIK 0000946644

  • Non-accelerated filer
  • Smaller reporting company

AIM ImmunoTech Inc.

Sign in to watch
Ticker
AIM
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
520845822
Phone
+1 352-448-7797
Business address
2117 SW HIGHWAY 484, OCALA, FL, 32801
Former names
AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
Open-market buys, last 90 days
$49,596
in 12 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$49,596. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Equels Thomas K +$50K CEO & President 12 filings

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-05-08 PASCALE ADAM CFO Conversion +35,000 147,148
2019-03-18 PASCALE ADAM CFO Conversion +50,000 112,148
2019-02-27 PASCALE ADAM CFO Option exercise +10 10
2019-02-27 PASCALE ADAM CFO Option exercise +50,000 50,000
2019-02-27 PASCALE ADAM CFO Option exercise · Subr Rights(to buy) +10 $1,000.00 $10K 0
2019-01-28 PASCALE ADAM CFO Grant or award · Options to buy Common Stock +142,046 142,046
2018-11-27 PASCALE ADAM CFO Grant or award +2,500 62,148
2018-11-14 PASCALE ADAM CFO Grant or award · Options to buy Common Stock +1,000 1,000
2018-10-17 PASCALE ADAM CFO Grant or award · Options to buy Common Stock +94,697 94,697
2018-07-23 PASCALE ADAM CFO Purchase +32,259 $0.31 $10K 59,648
2018-07-18 PASCALE ADAM CFO Grant or award · Options to buy Common Stock +53,763 53,763
2018-05-16 PASCALE ADAM CFO Grant or award · Options to buy Common Stock +83,334 83,334
2018-04-12 PASCALE ADAM CFO Grant or award · Options to buy Common Stock +75,000 75,000

Page 1 of 1 · 13 trades